GLP-1 agonists, also known as incretin mimetics, are a class of medication that is primarily used to treat type 2 diabetes and, in some cases, obesity. "The glucagon-like peptide (GLP-1 ...

Both of them are in the class of drugs known as incretin mimetics but have some differences. Mounjaro is a GLP-1 and GIP receptor agonist. Ozempic acts only on GLP-1. Mounjaro lowers fasting and ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

They are in a class of drugs known as incretin mimetics. GLP-1 drugs are more commonly known by their brand names like Ozempic, Wegovy (semaglutide), Mounjaro (tirzepatide), and Victoza (liraglutide).